Home / Health / First anti-postpartum drug approved by the FDA

First anti-postpartum drug approved by the FDA

The first drug specifically designed to combat postpartum depression was approved Tuesday by the US Food and Drug Administration (FDA).

Zulresso, a drug developed by Sage Therapeutics, is administered as an IV drug "as a continuous infusion" over a period of 60 hours or two and a half days, the agency announced in a press release.


In a company-funded facility study on new mothers with moderate or severe postpartum depression, it was reported that half of the women receiving Zulresso had within two and a half years An end to the depression ̵

1; about twice as fast as in a peer group receiving sham treatments.

"Baby blues" after birth is common according to Mayo Clinic. After birth, "most" new mothers experience a range of symptoms, including mood swings, crying, sleep disturbances, and irritability.

But some other mothers experience stronger, heavier emotions called postpartum depression.

Excessive crying, overpowering fatigue, difficulty in contact with the newborn, fear of inadequate motherhood, or total hopelessness are symptoms that can occur postpartum depression in the first few weeks after birth, but can start sooner or later ,

It affects about 400,000 American women a year and can be treated with antidepressants, which can take six to eight weeks and can not help everyone, or with counseling.

DEPRESSION AND SUICIDAL THOUGHTS DOUBLED IN YOUNG AMERICANS, STUDY SAYS 19659006] "Postpartum depression is a serious condition that can be life-threatening in serious illnesses Women may have thoughts of hurting themselves or har In their press release, Dr Tiffany Farchione of the FDA's Department of Psychiatric Products

Farchione added, "Postpartum depression can also affect mother-child attachment. This approval marks the first time that a drug has been specifically approved for the treatment of postpartum depression. This is an important new treatment option. "

Zulresso's compound, brexanolone, mimics a derivative of the naturally occurring hormone progesterone, whose levels may drop later Sage chief executive Dr. Jeff Jnas says the infusion helps maintain normal levels and Emotions Restore


Sage said that Zulresso without insurance costs $ 34,000 Infusion Center: Whether the treatment is covered by insurance will be covered by each insurance company Expenses are also set according to plan.

The company, which is developing similar pills, plans to begin selling the drug in late June.

The Associated Press contributed to this report at.

Source link